94 related articles for article (PubMed ID: 16823067)
1. Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer.
McAleese JJ; Bishop KM; A'Hern R; Henk JM
Br J Radiol; 2006 Jul; 79(943):608-13. PubMed ID: 16823067
[TBL] [Abstract][Full Text] [Related]
2. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730
[TBL] [Abstract][Full Text] [Related]
4. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study.
Masucci G; Broman P; Kelly C; Lindahl S; Malmberg L; Reizenstein J; Alenius M; Lewensohn R
Med Oncol; 2005; 22(3):247-56. PubMed ID: 16110136
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
8. Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy.
Rosso M; Blasi G; Gherlone E; Rosso R
J Chemother; 1997 Oct; 9(5):382-5. PubMed ID: 9373795
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report.
Nicolatou O; Sotiropoulou-Lontou A; Skarlatos J; Kyprianou K; Kolitsi G; Dardoufas K
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):551-6. PubMed ID: 9806514
[TBL] [Abstract][Full Text] [Related]
10. Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer.
Wagner W; Alfrink M; Haus U; Matt J
Anticancer Res; 1999; 19(1B):799-803. PubMed ID: 10216495
[TBL] [Abstract][Full Text] [Related]
11. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis.
Sprinzl GM; Galvan O; de Vries A; Ulmer H; Gunkel AR; Lukas P; Thumfart WF
Eur J Cancer; 2001 Nov; 37(16):2003-9. PubMed ID: 11597377
[TBL] [Abstract][Full Text] [Related]
12. The optimal use of granulocyte macrophage colony stimulating factor in radiation induced mucositis in head and neck squamous cell carcinoma.
Patni N; Patni S; Bapna A
J Cancer Res Ther; 2005; 1(3):136-41. PubMed ID: 17998644
[TBL] [Abstract][Full Text] [Related]
13. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial.
Hejna M; Köstler WJ; Raderer M; Steger GG; Brodowicz T; Scheithauer W; Wiltschke C; Zielinski CC
Eur J Cancer; 2001 Nov; 37(16):1994-2002. PubMed ID: 11597376
[TBL] [Abstract][Full Text] [Related]
14. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.
Stokman MA; Spijkervet FK; Boezen HM; Schouten JP; Roodenburg JL; de Vries EG
J Dent Res; 2006 Aug; 85(8):690-700. PubMed ID: 16861284
[TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.
Ibrahim EM; al-Mulhim FA
Med Oncol; 1997 Mar; 14(1):47-51. PubMed ID: 9232612
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Ryan CW; Vogelzang NJ; Dumas MC; Kuzel T; Stadler WM
Cancer; 2000 Mar; 88(6):1317-24. PubMed ID: 10717612
[TBL] [Abstract][Full Text] [Related]
17. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
Terhaard CH; Kal HB; Hordijk GJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
[TBL] [Abstract][Full Text] [Related]
18. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Hoffman KE; Pugh SL; James JL; Scarantino C; Movsas B; Valicenti RK; Fortin A; Pollock J; Kim H; Brachman DG; Berk LB; Bruner DW; Kachnic LA
Qual Life Res; 2014 Aug; 23(6):1841-58. PubMed ID: 24492945
[TBL] [Abstract][Full Text] [Related]
19. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]